Search - tctmd.com

Displaying 181 - 200 of 420

Sort: Relevancy | Date

News Daily News

Subestudio del HORIZONS-AMI: Las Mujeres Corren Más Riego Hemorrágico Post-STEMI

Yael L. Maxwell

October 03, 2014

Presentation TCT 2014

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Presenter: Timothy Henry

September 16, 2014

Presentation TCT 2014

Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention

Presenter: Ahmed Rehmani

September 16, 2014

Presentation TCT 2014

TCT 460: Bivalirudin Versus Heparin During Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials

Presenter: John A. Bittl, Tullio Palmerini, Salvatore Cassese, MD

September 15, 2014

Presentation TCT 2014

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Presenter: Roxana Mehran, Harvey D. White, Yaling Han

September 15, 2014

News Conference News TCT 2014

Post-procedural Consent in STEMI Trials Debated

September 15, 2014

News Industry News

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

September 15, 2014

Presentation TCT 2014

TCT 467: Bivalirudin vs Heparin for Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Controlled Trials

Presenter: David J. Moliterno, E. Magnus Ohman, Duane S. Pinto, Michael Lipinski

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Rod H. Stables

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Gregg W. Stone

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Heparin!

Presenter: Stefanie Schüpke

September 14, 2014

Presentation TCT 2014

The Data Strongly Support Bivalirudin!

Presenter: Roxana Mehran

September 14, 2014

News Conference News TCT 2014

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

September 14, 2014

Presentation TCT 2014

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

Presenter: Patrick W. Serruys, Jurrien M. Ten Berg

September 13, 2014

News Conference News TCT 2014

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

September 13, 2014

News Conference News TCT 2014

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

September 13, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Daily News

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

L.A. McKeown

September 11, 2014

News Daily News

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

September 02, 2014

News Daily News

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

September 02, 2014

Advertisement

Subestudio del HORIZONS-AMI: Las Mujeres Corren Más Riego Hemorrágico Post-STEMI

Safety and Effectiveness of Prasugrel vs_ Clopidogrel in the Setting of Bivalirudin vs_ Heparin Use: 30-day Results from TRANSLATE-ACS

Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention

TCT 460: Bivalirudin Versus Heparin During Percutaneous Coronary Intervention: A Meta-analysis of Randomized Trials

BRIGHT: A Prospective, Randomized Trial of Bivalirudin Monotherapy Versus Heparin Monotherapy Versus Heparin Plus Tirofiban in Patients with Acute Myocardial Infarction Undergoing Coronary Intervention

Post-procedural Consent in STEMI Trials Debated

Extended Follow-Up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and without Glycoprotein IIB, IIIA Inhibition in Patients with Acute Myocardial Infarction

TCT 467: Bivalirudin vs Heparin for Percutaneous Coronary Intervention: An Updated Meta-analysis of Randomized Controlled Trials

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

The Data Strongly Support Heparin!

The Data Strongly Support Bivalirudin!

EUROMAX Substudy: Bivalirudin Noninferior to Heparin Plus GPI for Myocardial Reperfusion

EUROMAX STR: ST-Segment Resolution Analysis in Patients with ST-Segment Elevation Myocardial Infarction Randomized to Prehospital Bivalirudin Versus Heparin Plus a Routine Glycoprotein IIb/IIIa Inhibitor Prior to Primary Percutaneous Coronary Intervention

Study Identifies Predictors of Stent Thrombosis, Mortality After Primary PCI

Meta-analysis: Less Bleeding, More Stent Thrombosis with Bivalirudin vs. Heparin After PCI

European Societies Release Updated Revascularization Guidelines for CAD

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

Subestudio del HORIZONS-AMI: La Anticoagulación Primaria Post-PCI Da Peores Resultados

HORIZONS-AMI亚组研究：直接PCI后抗凝血产生的结果更差

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content